| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |